Accelerating Scientific Discovery. Transforming Healthcare.
AI-Driven Drug Discovery, Translational Research & Molecular Diagnostics
From computational drug discovery and multi-omics analytics to laboratory validation and molecular diagnostics, we deliver end-to-end scientific innovation through one integrated partner.
Trusted worldwide
Four regionsTrusted by researchers, biotech innovators, healthcare organizations, universities, and life sciences partners worldwide.
- 20+
- Specialized Scientific Services
- 5
- Integrated Technology Platforms
- AI + Laboratory
- End-to-End Scientific Workflow
- Global
- Middle East • United States • Canada • India
One Integrated Partner Across the Innovation Lifecycle
Scientific innovation shouldn’t require multiple vendors, disconnected workflows, and fragmented data.
Prognica Labs combines artificial intelligence, computational biology, bioinformatics, laboratory sciences, and molecular diagnostics into one unified scientific ecosystem.
We help organizations move seamlessly from:
DiscoveryValidationDevelopmentManufacturingCommercialization
Our Services
Four disciplines, one scientific team
Each one stands on its own. Together they are the reason nothing has to be handed off.
- 01Discovery
AI Drug Discovery
ExploreTarget identification, drug repurposing, virtual screening, molecular dynamics and lead optimisation.
- 02Data
Bioinformatics & Multi-Omics
ExploreMulti-omics analytics, biomarker discovery and validation, and clinical-grade variant interpretation.
- 03Laboratory
Translational Biology
ExploreWet-lab target validation and PCR/qPCR assay development - run by the team that made the prediction.
- 04Product
Molecular Diagnostics
ExploreCompanion diagnostics, liquid biopsy and diagnostic kit development, through to a registrable product.
The platform
Five AI platforms behind the science
Every engagement runs on the same tooling our own scientists use. Explainable, benchmarked and source-traceable throughout.
01Autonomous Asset Discovery
Autonomously surface, rank and evidence overlooked, shelved and repurposable assets, and discover novel targets, biomarkers and combinations - every claim explainable and source-traceable.
Asset surfacingNovel targetsTraceable evidence
02In-Silico Evaluation Suite
A validated computational chemistry and biology workbench: manage structures, dock, screen, simulate, predict ADMET and toxicity, and optimise candidates - every method benchmarked and uncertainty-aware.
Docking & screeningSimulationADMET & toxicity
03Market & Commercial Insight
Quantify the commercial opportunity, pricing, market access, competition and forecast for an asset or indication - with transparent, source-backed, back-tested models.
Pricing & accessCompetitionBack-tested forecasts
04Clinical Operations
Design, simulate and de-risk clinical trials - feasibility, recruitment, sites, eligibility, risk, adaptive design, timelines and budget - validated against real trial histories.
Trial digital twinFeasibilityAdaptive design
05Business Development
Value assets, benchmark deals, match buyers and investors, run diligence, and manage the portfolio and pipeline - quantitatively, with valuation driven by real platform evidence.
ValuationDeal benchmarkingDiligence
How the work flows
The Prognica Scientific Workflow
One unbroken workflow, from first hypothesis to commercial supply - with no re-scoping and no re-contracting between the stages.
- AI-driven target discovery
- Virtual screening
- Drug repurposing
- Knowledge graphs
- Molecular modeling
- Genomics
- Transcriptomics
- Proteomics
- Clinical bioinformatics
- Biomarker discovery
- Laboratory experiments
- Target validation
- PCR/qPCR assays
- Protein expression
- Functional biology
- Diagnostic assays
- Companion diagnostics
- Liquid biopsy
- Clinical applications
- OEM diagnostics
- Quality systems
- Regulatory documentation
- Commercial supply
Our Partners
Awards & Recognition
In Media
Global reach
Where we work
- Dubai, UAE
- Mumbai, India
- United States
- Canada